In conclusion, we report here that CD34+ progenitor cells obtained from CP-CML patients, compared to CD34+ from healthy donors, are characterized by a specific proteomic and phospho-proteomic profile that promotes quiescence and survival. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.